LOC93622: A Potential Drug Target and Biomarker (G93622)

Target Name: LOC93622

NCBI ID: G93622

LOC93622

Other Name(s): LOC93622 variant 1 | Morf4 family associated protein 1 like 1 pseudogene, transcript variant 1 | UPP | Morf4 family associated protein 1 like 1

LOC93622: A Potential Drug Target and Biomarker

LOC93622 is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to an increase in temperature.

LOC93622 is known for its ability to interact with a variety of molecules, including transcription factors, DNA-binding proteins, and protein kinases. It has been shown to play a role in a number of cellular processes, including cell survival, metabolism, and inflammation.

One of the most promising aspects of LOC93622 is its potential as a drug target. LOC93622 has been shown to interact with a variety of small molecules, including drugs that are used to treat a variety of diseases, such as cancer, neurodegenerative diseases, and autoimmune disorders.

In addition, LOC93622 has also been shown to interact with ligand drugs, such as small molecules, peptides, and proteins, which can modulate its activity and activity. This suggests that LOC93622 may be a useful biomarker for the development of drug targets for these diseases.

LOC93622 is also a potential biomarker for certain diseases, such as cancer. have shown that LOC93622 is expressed in a variety of tissues and that it is highly sensitive to changes in cellular signaling pathways.

LOC93622 is also a potential biomarker for neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. have shown that LOC93622 is expressed in the brains of individuals with these conditions and that it is involved in the development and progression of these diseases.

LOC93622 is also a potential biomarker for autoimmune disorders, such as rheumatoid arthritis, lupus, and multiple sclerosis. have shown that LOC93622 is expressed in the tissues of individuals with these conditions and that it is involved in the development and progression of these diseases.

In conclusion, LOC93622 is a protein that has been shown to play a role in a variety of cellular processes and that has the potential as a drug target. LOC93622 is expressed in various tissues throughout the body and has been shown to interact with a variety of small molecules and proteins. Additionally, LOC93622 is also a potential biomarker for a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of LOC93622 as a drug target and biomarker.

Protein Name: Morf4 Family Associated Protein 1 Like 1

The "LOC93622 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC93622 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets